OverviewSuggest Edit

Thermo Fisher Scientific is a global provider of laboratory products and services, life science solutions, analytical instruments, and specialty diagnostics. It operates through 4 segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease. The Analytical Instruments segment provides instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment delivers diagnostic test kits, reagents, culture media, instruments, and associated products. The Laboratory Products and Services segment offers self-manufactured and sourced products as well as outsourced services used by the pharmaceutical and biotech industries for drug development, clinical trial logistics, and commercial drug manufacturing.
TypePublic
Founded1956
HQWaltham, MA, US
Websitethermofisher.com
Overall CultureB-

Latest Updates

Employees (est.) (Dec 2020)80,000(+7%)
Job Openings5
Revenue (FY, 2020)$32.2 B(+27%)
Share Price (Mar 2021)$462.1
Cybersecurity ratingCMore

Key People/Management at Thermo Fisher Scientific

Marc N. Casper

Marc N. Casper

Chairman, President and Chief Executive Officer
Konrad Bauer

Konrad Bauer

Senior Vice President, Global Business Services
Michael A. Boxer

Michael A. Boxer

Senior Vice President and General Counsel
Lisa P. Britt

Lisa P. Britt

Senior Vice President, Chief Human Resources Officer
Tom Grover

Tom Grover

Vice President, Financial Operations
Mark P. Stevenson

Mark P. Stevenson

Executive Vice President and Chief Operating Officer
Show more

Thermo Fisher Scientific Office Locations

Thermo Fisher Scientific has offices in Waltham, Agawam, Allentown, Ann Arbor and in 351 other locations
Waltham, MA, US (HQ)
168 3rd Ave
Agawam, MA, US
325 Bowles Rd
Allentown, PA, US
7554 Schantz Rd
Ann Arbor, MI, US
110 Miller Ave
Asheville, NC, US
275 Aiken Rd
Auburn, AL, US
2039 McMillan St
Show all (439)

Thermo Fisher Scientific Financials and Metrics

Thermo Fisher Scientific Revenue

Embed Graph
View revenue for all periods
Thermo Fisher Scientific's revenue was reported to be $32.22 b in FY, 2020 which is a 26.1% increase from the previous period.
USD

Revenue (FY, 2020)

32.2b

Revenue growth (FY, 2019 - FY, 2020), %

26.1%

Gross profit (FY, 2020)

16.5b

Gross profit margin (FY, 2020), %

51.2%

Net income (FY, 2020)

6.4b

EBIT (FY, 2020)

7.8b

Market capitalization (2-Mar-2021)

182.0b

Closing stock price (2-Mar-2021)

462.1

Cash (31-Dec-2020)

10.3b

EV

193.4b
Thermo Fisher Scientific's current market capitalization is $182 b.
Annual
USDFY, 2018FY, 2019FY, 2020

Revenue

24.4b25.5b32.2b

Revenue growth, %

16%5%26%

Cost of goods sold

13.5b14.2b15.7b

Gross profit

10.9b11.3b16.5b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

5.9b6.1b5.9b6.1b6.3b6.3b6.2b6.9b8.5b

Cost of goods sold

3.3b3.3b3.3b2.4b3.5b3.5b3.5b3.4b4.2b

Gross profit

2.6b2.7b2.6b3.7b2.8b2.8b2.7b3.5b4.3b

Gross profit Margin, %

44%45%44%61%45%44%44%51%51%
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

2.1b2.4b10.3b

Accounts Receivable

4.1b4.3b5.7b

Inventories

3.0b3.4b4.0b

Current Assets

10.6b11.9b22.0b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

950.0m937.0m1.1b1.1b2.3b1.3b3.0b5.8b7.5b

Accounts Receivable

4.0b3.9b3.9b4.2b4.1b4.4b4.5b4.5b5.2b

Inventories

2.9b2.9b3.0b3.1b3.2b3.3b3.5b3.6b3.8b

Current Assets

9.6b9.5b9.6b9.9b11.2b10.5b12.7b15.8b18.2b
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

2.9b3.7b6.4b

Depreciation and Amortization

2.3b2.3b2.3b

Inventories

(324.0m)(458.0m)(508.0m)

Accounts Payable

201.0m266.0m59.0m
Quarterly
USDQ1, 2018

EV/EBIT

131.1 x

EV/CFO

1.3 k x

Debt/Equity

0.8 x

Debt/Assets

0.4 x

Financial Leverage

2.2 x

P/E Ratio

144.4
Show all financial metrics

Thermo Fisher Scientific Operating Metrics

Thermo Fisher Scientific's Customers was reported to be 400 k in FY, 2020. Thermo Fisher Scientific's Backlog was reported to be $7.8b in FY, 2019.
FY, 2017FY, 2018FY, 2019FY, 2020

Backlog

$4.46 b$5.09 b$7.77 b

Backlog (Analytical Instruments)

$2.05 b$2.24 b$2.20 b

Backlog (Life Sciences Solutions)

$594 m$647 m$893 m

Customers

400 k400 k400 k400 k
Show all operating metrics

Thermo Fisher Scientific Acquisitions / Subsidiaries

Company NameDateDeal Size
HenogenJanuary 15, 2021€725 m
PhinotexDecember 31, 2020
QiagenMarch 03, 2020$11.50 b
Brammer BioJune 17, 2019$1.67 b
HighChemJune 06, 2019
Gatan IncJune 29, 2018$925 m
IntegenXMarch 16, 2018
PatheonAugust 29, 2017$7.20 b
Linkage Biosciences, Inc.July 12, 2017
Patheon Inc.May 15, 2017$7.20 b
Show more

Thermo Fisher Scientific Revenue Breakdown

Embed Graph

Thermo Fisher Scientific revenue breakdown by business segment: 35.1% from Laboratory Products and Services, 15.3% from Specialty Diagnostics, 14.7% from Analytical Instruments and 34.9% from Life Sciences Solutions

Thermo Fisher Scientific revenue breakdown by geographic segment: 8.7% from China, 51.0% from United States and 40.3% from Other

Human Capital Metrics

Thermo Fisher Scientific's employees are reported to be approximately 41% female and 59% male.
Embed Graph
Show all human capital metrics

Thermo Fisher Scientific Cybersecurity Score

Cybersecurity ratingPremium dataset

C

77/100

SecurityScorecard logo

Thermo Fisher Scientific Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

60-79

out of 100

CSRHub logo

Thermo Fisher Scientific Online and Social Media Presence

Embed Graph

Thermo Fisher Scientific Company Culture

  • Overall Culture

    B-

    68/100

  • CEO Rating

    B

    71/100

  • Compensation

    B

    70/100

  • Diversity

    C

    64/100

Learn more on Comparably

Thermo Fisher Scientific News and Updates

Could Thermo Fisher Scientific Stock Jump To Fresh Highs?

Despite already rising 1.8x from its low in March 2020, at the current price of $460 per share, we believe Thermo Fisher Scientific stock has further upside potential. TMO stock has increased from $255 to $460 off the recent bottom, a little more than the S&P which increased by around 70% from..…

Global Digital Genome Market (2021 to 2028) - Players Include Illumina, Thermo Fisher Scientific and Pacific Bioscience Among Others

Dublin, March 03, 2021 (GLOBE NEWSWIRE) -- The "Global Digital Genome Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. The publisher predicts that the global market for digital genome would witness a CAGR of 9.57% over the forecast period 2021-2028. It garnered $10061.…

Thermo Fisher completes Mesa Biotech acquisition

Thermo Fisher Scientific (NYSE:TMO) announced today that it completed its previously announced acquisition of Mesa Biotech.

Insights on the Animal Blood Plasma Products and Derivatives Global Market to 2027 - Featuring Anzco Foods, MilliporeSigma and Thermo Fisher Scientific Among Others

Dublin, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The "Animal Blood Plasma Products and Derivatives - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 7th edition of this report. The 143-page repo…

Worldwide Apoptosis Assay Industry to 2028 - Players Include Becton Dickinson, Thermo Fisher Scientific and Bio-Rad Laboratories Among Others

Dublin, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The "Apoptosis Assay Market Share, Size, Trends, Industry Analysis Report, By Product; By Technique; By Assay Type; By End-Use; By Regions; Segment Forecast, 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global apoptosis assay …

Thermo Fisher Scientific Increases Quarterly Dividend

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.26 per common share, payable on April 16, 2021, to shareholders of record as of March 16, 2021. This reflects an 18% increase ove…
Show more

Thermo Fisher Scientific Frequently Asked Questions

  • When was Thermo Fisher Scientific founded?

    Thermo Fisher Scientific was founded in 1956.

  • Who are Thermo Fisher Scientific key executives?

    Thermo Fisher Scientific's key executives are Marc N. Casper, Konrad Bauer and Michael A. Boxer.

  • How many employees does Thermo Fisher Scientific have?

    Thermo Fisher Scientific has 80,000 employees.

  • What is Thermo Fisher Scientific revenue?

    Latest Thermo Fisher Scientific annual revenue is $32.2 b.

  • What is Thermo Fisher Scientific revenue per employee?

    Latest Thermo Fisher Scientific revenue per employee is $402.7 k.

  • Who are Thermo Fisher Scientific competitors?

    Competitors of Thermo Fisher Scientific include Illumina, Bruker and Avantor.

  • Where is Thermo Fisher Scientific headquarters?

    Thermo Fisher Scientific headquarters is located at 168 3rd Ave, Waltham.

  • Where are Thermo Fisher Scientific offices?

    Thermo Fisher Scientific has offices in Waltham, Agawam, Allentown, Ann Arbor and in 351 other locations.

  • How many offices does Thermo Fisher Scientific have?

    Thermo Fisher Scientific has 439 offices.